For advancing bioscience and medical development
Through providing solutions for solving problems in the bioscience and medical fields, Nikon supports various fields globally such as advanced research, early development of regenerative medicine and retinal diagnostic imaging for prevention, diagnosis, treatment and prognosis management.
Following a collaboration agreement with Lonza of Switzerland, we started contract manufacturing business of cells, etc. for regenerative medicine with a new, wholly owned subsidiary Nikon CeLL innovation Co., Ltd. We will advance toward expedited clinical application of regenerative medicine in Japan. With our inverted routine microscopes and inverted research microscopes designed to maximize efficiency in microscopic observation, Nikon supports researchers who unravel the mechanisms and principles of life.
Super Resolution Microscope N-SIM
N-SIM (Nikon's Structured Illumination Microscopy), a combination of technology licensed by the University of California, San Francisco, and Nikon's optical technology, allows observation of the minute intracellular structures of live cells with a resolution of approx. 100 nm — about double that of conventional optical microscopes.
Super Resolution Microscope N-STORM
N-STORM, which employs Stochastic Optical Reconstruction Microscopy technology licensed from Harvard University, has increased resolution to more than 10 times that of conventional optical microscopes. N-STORM delivers rich information that enhances understanding of the structure of living cells and biological phenomena at molecular levels.
Inverted Microscope ECLIPSE Ti2
The incredibly wide field of view and quick coordination with diverse accessories contribute to fast acquisition of vast data, making this microscope an integrated live-cell imaging platform. The unique Assist Guide function provides strong support for cutting-edge life science research, regardless of the users' skill levels.
Cell Culture Observation System BioStation CT
The BioStation CT allows time-lapse observation of cells while they are being cultured in the stable environment of an incubator. This not only mitigates the burden placed on researchers, but simultaneously enables tracking observation of cells without inflicting stress on them.
In 2015, Nikon acquired Optos Plc, a leading company in the retinal diagnostic imaging equipment market, as a wholly owned subsidiary, then jointly developed retinal diagnostic imaging equipment. In 2016, Nikon and Verily Life Sciences LLC established a strategic alliance to develop machine learning-enabled solutions for retinal diagnostic imaging equipment fields. Utilizing Optos technology and cutting-edge AI technology, we aim to achieve innovative solutions leading to the earlier diagnosis of various diseases, contributing to the improvement of people's quality of life all over the world.
Ultra-wide field retinal imaging device
With its wide field of view of 200°, Optos Plc's Ultra-wide field retinal imaging device capture images covering more than 80% of the retinal area in non-mydriatic, non-contact photography. It allows easy detection of symptoms appearing in peripherals — that have previously been difficult to spot.